The global vitiligo treatment market is anticipated to grow at a considerable CAGR of 5.5% during the forecast period (2022-2028). The increasing disease prevalence for vitiligo across the globe is one of the prime factors affecting and driving the market for vitiligo treatment. As per the information provided by VR Foundation, Inc., in 2020 the total number of people suffering from vitiligo is estimated nearly 65-95 million people across the globe. Generally, vitiligo is related to autoimmune illnesses, also has a negative effect on hearing and eyesight, and is not related to any boundaries of race, ethnicity, or gender. However, various treatments, including topical creams and light therapy, can support some patients as well.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/vitiligo-treatment-market
Moreover, to gain on the opportunity key players operating in the global vitiligo treatment market had been adopting strategies such as new launches to achieve major market share. For instance, in December 2021, Incyte Corp. had set forth that the U.S. Food and Drug Administration (FDA) had accepted for priority review for the supplemental New Drug Application (sNDA) that is ruxolitinib cream which is considered as a topical JAK inhibitor, for the purpose of providing effective treatment in adolescents and adults with vitiligo.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Product
- By Diagnosis
- By Treatment
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- AVITA Medical, Incyte Corp., TWi Biotechnology, Dermavant Sciences, Inc., and Clinuvel Pharmaceuticals Ltd.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Vitiligo Treatment Market Report Segment
By Type
- Non-Segmental Vitiligo
- Segmental Vitiligo
By Treatment
- Therapy
- Surgery
- Medication
By End-User
- Hospitals
- Aesthetic Clinics
A full report of Vitiligo Treatment Market is available at: https://www.omrglobal.com/industry-reports/vitiligo-treatment-market
Vitiligo Treatment Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Arcutis Biotherapeutics
- AVITA Medical
- CLINUVEL PHARMACEUTICALS LTD.
- Bioniz Therapeutics
- Reddy’s Laboratories Ltd.
- Dermavant Sciences, Inc.
- Edesa Biotech, Inc.
- Eli Lilly and Co.
- Incyte Corp.
- TWi Biotechnology
- Temprian Therapeutics Inc.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
